Aclaris Therapeutics to Participate in the LifeSci Partners Immunology & Inflammation Symposium

Rhea-AI Summary

Aclaris Therapeutics (NASDAQ: ACRS) announced participation in a virtual fireside chat at the LifeSci Partners Immunology & Inflammation Symposium on May 11, 2022, at 9:00 a.m. ET. President and CEO Dr. Neal Walker and Consultant Walter Smith will discuss the company’s initiatives in developing novel drug candidates for immuno-inflammatory diseases. The chat will be accessible via Aclaris’ website and archived for 30 days. Aclaris is focused on innovative treatments for patients with unmet medical needs in immuno-inflammatory diseases.

WAYNE, Pa., May 03, 2022 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that Dr. Neal Walker, President and CEO, and Walter Smith, Scientific and Business Development Consultant, of Aclaris will participate in a virtual fireside chat at the LifeSci Partners Immunology & Inflammation Symposium on Wednesday, May 11, 2022 at 9:00 a.m. ET.

A webcast of the fireside chat may be accessed through the “Events” page of the “Investors” section of Aclaris’ website, www.aclaristx.com. The webcast will be archived for at least 30 days on the Aclaris website.

About Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation. For additional information, please visit www.aclaristx.com.

Aclaris Contact

investors@aclaristx.com

FAQ

When will Aclaris Therapeutics participate in the LifeSci Partners Immunology & Inflammation Symposium?

Aclaris Therapeutics will participate in the symposium on May 11, 2022, at 9:00 a.m. ET.

Who from Aclaris will be speaking at the symposium?

Dr. Neal Walker, President and CEO, and Walter Smith, Scientific and Business Development Consultant, will be speaking.

How can I access the webcast of Aclaris' fireside chat?

The webcast can be accessed through the 'Events' page of the 'Investors' section on Aclaris’ website.

Will the Aclaris webcast be available after the event?

Yes, the webcast will be archived for at least 30 days on Aclaris’ website.

What is the focus of Aclaris Therapeutics?

Aclaris Therapeutics focuses on developing novel drug candidates for patients with immuno-inflammatory diseases.